BCLI
Price:
$0.61
Market Cap:
$6.73M
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment o...[Read more]
Industry
Biotechnology
IPO Date
2003-10-07
Stock Exchange
NASDAQ
Ticker
BCLI
According to Brainstorm Cell Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 223.86%. This represents a change of 618.48% compared to the average of 31.16% of the last 4 quarters.
The mean historical ROE of Brainstorm Cell Therapeutics Inc. over the last ten years is 51.08%. The current 223.86% ROE has changed 338.24% with respect to the historical average. Over the past ten years (40 quarters), BCLI's ROE was at its highest in in the December 2022 quarter at 166.43%. The ROE was at its lowest in in the March 2019 quarter at -1542.02%.
Average
51.08%
Median
-72.15%
Minimum
-278.07%
Maximum
805.21%
Discovering the peaks and valleys of Brainstorm Cell Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 230.18%
Maximum Annual ROE = 805.21%
Minimum Annual Increase = -736.80%
Minimum Annual ROE = -278.07%
| Year | ROE | Change |
|---|---|---|
| 2024 | -149.70% | -142.30% |
| 2023 | 353.89% | -56.05% |
| 2022 | 805.21% | -736.80% |
| 2021 | -126.45% | 40.97% |
| 2020 | -89.70% | -147.15% |
| 2019 | 190.24% | -168.41% |
| 2018 | -278.07% | 230.18% |
| 2017 | -84.22% | 67.39% |
| 2016 | -50.31% | -16.26% |
| 2015 | -60.08% | -56.63% |
The current ROE of Brainstorm Cell Therapeutics Inc. (BCLI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
336.46%
5-year avg
158.65%
10-year avg
51.08%
Brainstorm Cell Therapeutics Inc.’s ROE is less than NeuroSense Therapeutics Ltd. (2.72%), greater than Matinas BioPharma Holdings, Inc. (-249.82%), greater than Adial Pharmaceuticals, Inc. (-197.71%), greater than Cardio Diagnostics Holdings, Inc. (-72.79%), less than HCW Biologics Inc. (507.82%), greater than Impact BioMedical Inc. (-528.69%), greater than Acurx Pharmaceuticals, Inc. (-219.56%), greater than VYNE Therapeutics Inc. (-80.55%), greater than Addex Therapeutics Ltd (-66.77%), greater than BioCardia, Inc. (-58896.55%),
| Company | ROE | Market cap |
|---|---|---|
| 2.72% | $29.60M | |
| -249.82% | $4.17M | |
| -197.71% | $7.82M | |
| -72.79% | $5.55M | |
| 507.82% | $4.39M | |
| -528.69% | $5.88M | |
| -219.56% | $5.52M | |
| -80.55% | $6.24M | |
| -66.77% | $5.54M | |
| -58896.55% | $8.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brainstorm Cell Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Brainstorm Cell Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Brainstorm Cell Therapeutics Inc.'s ROE?
How is the ROE calculated for Brainstorm Cell Therapeutics Inc. (BCLI)?
What is the highest ROE for Brainstorm Cell Therapeutics Inc. (BCLI)?
What is the 3-year average ROE for Brainstorm Cell Therapeutics Inc. (BCLI)?
What is the 5-year average ROE for Brainstorm Cell Therapeutics Inc. (BCLI)?
How does the current ROE for Brainstorm Cell Therapeutics Inc. (BCLI) compare to its historical average?